{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:18:11Z","timestamp":1784557091295,"version":"3.55.0"},"reference-count":24,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["etj.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,13]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to prospectively evaluate the quality of postoperative neck ultrasound (POU) for thyroid cancer patients after implementing European Thyroid Association (ETA) guideline-based POU assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our analysis involved 672 differentiated thyroid cancer patients. POU report quality was compared between the implementation radiology group (IRG), which implemented ETA guideline-based assessment in 2018, and all non-implementation radiology groups (NIRG). Differences in POU quality were evaluated before and after the implementation of guideline-based assessment. Additionally, we evaluated the ability of serum thyroglobulin (Tg) level &lt;0.2 ng\/mL or between 0.21 and 0.99 ng\/mL and normal POU lesion status at 1-year follow-up to predict the absence of persistent disease or relapse at 3-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IRG had significantly higher mean utility scores for POU reports of abnormal thyroid bed nodules compared to NIRG (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). IRG's POU reports for suspicious nodules and lymph nodes were considered sufficient in 94% and 85% of cases, respectively, compared to 45% and 68% for NIRG. For patients with normal US lesion status and Tg &lt;0.2 ng\/mL or Tg 0.21\u20130.99 ng\/mL at 1-year follow-up, the negative predictive values were 96% for both.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Implementation of 2013 ETA POU-reporting guidelines allowed for the provision of high-quality POU reports, which may lead to increased accuracy in assessing the response to treatment and in estimating the risk of recurrence of thyroid cancer and likely reduce unnecessary repeat POU or FNA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-23-0110","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:14:13Z","timestamp":1689232453000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":5,"title":["Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study"],"prefix":"10.1530","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-0759","authenticated-orcid":true,"given":"Jiahui","family":"Wu","sequence":"first","affiliation":[{"name":"Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-8961","authenticated-orcid":true,"given":"Xunyang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Seal","sequence":"additional","affiliation":[{"name":"EFW Radiology, Calgary, Alberta, Canada"},{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthiv","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Diederichs","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Mayfair Radiology, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-268X","authenticated-orcid":true,"given":"Ralf","family":"Paschke","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Thyroid","first-page":"1","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"Haugen BRAlexander EKBible KCDoherty GMMandel SJNikiforov YEPacini FRandolph GWSawka AMSchlumberger M, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid2016261\u2013133. (https:\/\/doi.org\/10.1089\/thy.2015.0020)"},{"key":"bib2","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"3590","article-title":"Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer","volume":"92","author":"Leboulleux","year":"2007","unstructured":"Leboulleux SGirard ERose MTravagli JPSabbah NCaillou BHartl DMLassau NBaudin E & Schlumberger M. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism2007923590\u20133594. (https:\/\/doi.org\/10.1210\/jc.2007-0444)"},{"key":"bib3","series-title":"Thyroid","first-page":"1144","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","unstructured":"Randolph GWDuh QYHeller KSLiVolsi VAMandel SJSteward DLTufano RPTuttle RM & American Thyroid Association Surgical Affairs Committee\u2019s Taskforce on Thyroid Cancer Nodal Surgery. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid2012221144\u20131152. (https:\/\/doi.org\/10.1089\/thy.2012.0043)"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1561","article-title":"Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation","volume":"100","author":"Peiling Yang","year":"2015","unstructured":"Peiling Yang SBach AMTuttle RM & Fish SA. Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation. Journal of Clinical Endocrinology and Metabolism20151001561\u20131567. (https:\/\/doi.org\/10.1210\/jc.2014-3651)"},{"key":"bib5","series-title":"Thyroid","first-page":"187","article-title":"A follow-up strategy for patients with an excellent response to initial therapy for differentiated thyroid carcinoma: less is better","volume":"28","author":"Jeon","year":"2018","unstructured":"Jeon MJKim MPark SOh HSKim TYKim WBShong YK & Kim WG. A follow-up strategy for patients with an excellent response to initial therapy for differentiated thyroid carcinoma: less is better. Thyroid201828187\u2013192. (https:\/\/doi.org\/10.1089\/thy.2017.0130)"},{"key":"bib6","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"4981","article-title":"Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound","volume":"104","author":"Grani","year":"2019","unstructured":"Grani GRamundo VFalcone RLamartina LMontesano TBiffoni MGiacomelli LSponziello MVerrienti ASchlumberger M, Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound. Journal of Clinical Endocrinology and Metabolism20191044981\u20134989. (https:\/\/doi.org\/10.1210\/jc.2019-00962)"},{"key":"bib7","series-title":"European Thyroid Journal","first-page":"147","article-title":"2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer","volume":"2","author":"Leenhardt","year":"2013","unstructured":"Leenhardt LErdogan MFHegedus LMandel SJPaschke RRago T & Russ G. 2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. European Thyroid Journal20132147\u2013159. (https:\/\/doi.org\/10.1159\/000354537)"},{"key":"bib8","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"3036","article-title":"Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer","volume":"101","author":"Lamartina","year":"2016","unstructured":"Lamartina LGrani GBiffoni MGiacomelli LCostante GLupo SMaranghi MPlasmati KSponziello MTrulli F, Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism20161013036\u20133044. (https:\/\/doi.org\/10.1210\/jc.2016-1440)"},{"key":"bib9","series-title":"Radiology","first-page":"374","article-title":"Role of sonographic characteristics of thyroid bed lesions identified following thyroidectomy in the diagnosis or exclusion of recurrent cancer","volume":"299","author":"Frates","year":"2021","unstructured":"Frates MCParziale MPAlexander EKBarletta JA & Benson CB. Role of sonographic characteristics of thyroid bed lesions identified following thyroidectomy in the diagnosis or exclusion of recurrent cancer. Radiology2021299374\u2013380. (https:\/\/doi.org\/10.1148\/radiol.2021201596)"},{"key":"bib10","series-title":"Thyroid","first-page":"997","article-title":"Changes in serum thyroglobulin levels after lobectomy in patients with low-risk papillary thyroid cancer","volume":"28","author":"Park","year":"2018","unstructured":"Park SJeon MJOh HSLee YMSung TYHan MHan JMKim TYChung KWKim WB, Changes in serum thyroglobulin levels after lobectomy in patients with low-risk papillary thyroid cancer. Thyroid201828997\u20131003. (https:\/\/doi.org\/10.1089\/thy.2018.0046)"},{"key":"bib11","series-title":"Thyroid","first-page":"1509","article-title":"The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting","volume":"32","author":"Wu","year":"2022","unstructured":"Wu JHu XYGhaznavi SKinnear SSymonds CJGrundy PParkins VMSharma PLamb DKhalil M, The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting. Thyroid2022321509\u20131518. (https:\/\/doi.org\/10.1089\/thy.2022.0055)"},{"key":"bib12","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2692","article-title":"Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine","volume":"101","author":"Momesso","year":"2016","unstructured":"Momesso DPVaisman FYang SPBulzico DACorbo RVaisman M & Tuttle RM. Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. Journal of Clinical Endocrinology and Metabolism20161012692\u20132700. (https:\/\/doi.org\/10.1210\/jc.2015-4290)"},{"key":"bib13","series-title":"European Thyroid Journal","article-title":"Improvement in thyroid ultrasound report quality with radiologists\u2019 adherence to 2015 ATA or 2017 TIRADS: a population study","volume":"11","author":"Hu","year":"2022","unstructured":"Hu XYWu JSeal PGhaznavi SASymonds CKinnear S & Paschke R. Improvement in thyroid ultrasound report quality with radiologists\u2019 adherence to 2015 ATA or 2017 TIRADS: a population study. European Thyroid Journal202211. (https:\/\/doi.org\/10.1530\/ETJ-22-0035)"},{"key":"bib14","series-title":"Endocrine","first-page":"303","article-title":"Thyroid nodule ultrasound reports in routine clinical practice provide insufficient information to estimate risk of malignancy","volume":"61","author":"Symonds","year":"2018","unstructured":"Symonds CJSeal PGhaznavi SCheung WY & Paschke R. Thyroid nodule ultrasound reports in routine clinical practice provide insufficient information to estimate risk of malignancy. Endocrine201861303\u2013307. (https:\/\/doi.org\/10.1007\/s12020-018-1634-0)"},{"key":"bib15","series-title":"R: A Language and Environment for Statistical Computing","year":"2016","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: RFoundationforStatistical Computing, 2016."},{"key":"bib16","series-title":"Endocrine","first-page":"200","article-title":"Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH","volume":"55","author":"Pitoia","year":"2017","unstructured":"Pitoia FAbelleira E & Cross G. Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH. Endocrine201755200\u2013208. (https:\/\/doi.org\/10.1007\/s12020-016-1104-5)"},{"key":"bib17","series-title":"Thyroid","first-page":"613","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","unstructured":"Chou RDana TBrent GAGoldner WHaymart MLeung AMRingel MD & Sosa JA. Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review. Thyroid202232613\u2013639. (https:\/\/doi.org\/10.1089\/thy.2021.0666)"},{"key":"bib18","series-title":"Endocrine Practice","first-page":"220","article-title":"Prognosis of high-risk papillary thyroid cancer patients with pre-ablation stimulated Tg< 1 ng\/ml","volume":"25","author":"Tian","year":"2019","unstructured":"Tian TKou YHuang R & Liu B. Prognosis of high-risk papillary thyroid cancer patients with pre-ablation stimulated Tg< 1 ng\/ml. Endocrine Practice201925220\u2013225. (https:\/\/doi.org\/10.4158\/EP-2018-0436)"},{"key":"bib19","series-title":"Endocrine","first-page":"532","article-title":"Biochemical persistence in thyroid cancer: is there anything to worry about?","volume":"46","author":"Pitoia","year":"2014","unstructured":"Pitoia FAbelleira ETala HBueno FUrciuoli C & Cross G. Biochemical persistence in thyroid cancer: is there anything to worry about?Endocrine201446532\u2013537. (https:\/\/doi.org\/10.1007\/s12020-013-0097-6)"},{"key":"bib20","series-title":"Clinical Endocrinology","first-page":"100","article-title":"Dynamic risk stratification system in post\u2010lobectomy low\u2010risk and intermediate\u2010risk papillary thyroid carcinoma patients","volume":"89","author":"Cho","year":"2018","unstructured":"Cho JWLee YMLee YHHong SJ & Yoon JH. Dynamic risk stratification system in post\u2010lobectomy low\u2010risk and intermediate\u2010risk papillary thyroid carcinoma patients. Clinical Endocrinology201889100\u2013109. (https:\/\/doi.org\/10.1111\/cen.13721)"},{"key":"bib21","series-title":"European Thyroid Journal","first-page":"486","article-title":"Long-term outcome of lobectomy for thyroid cancer","volume":"10","author":"Bosset","year":"2021","unstructured":"Bosset MBonjour MCastellnou SHafdi-Nejjari ZBournaud-Salinas CDecaussin-Petrucci MLifante JCPerrin APeix JLMoulin P, Long-term outcome of lobectomy for thyroid cancer. European Thyroid Journal202110486\u2013494. (https:\/\/doi.org\/10.1159\/000510620)"},{"key":"bib22","series-title":"Thyroid","first-page":"1341","article-title":"Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system","volume":"20","author":"Tuttle","year":"2010","unstructured":"Tuttle RMTala HShah JLeboeuf RGhossein RGonen MBrokhin MOmry GFagin JA & Shaha A. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid2010201341\u20131349. (https:\/\/doi.org\/10.1089\/thy.2010.0178)"},{"key":"bib23","series-title":"Clinical Endocrinology","first-page":"132","article-title":"Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy","volume":"77","author":"Vaisman","year":"2012","unstructured":"Vaisman FMomesso DBulzico DAPessoa CHDias FCorbo RVaisman M & Tuttle RM. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clinical Endocrinology201277132\u2013138. (https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04342.x)"},{"key":"bib24","series-title":"Thyroid","first-page":"1401","article-title":"Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American Thyroid Society risk of recurrence classification systems","volume":"23","author":"Pitoia","year":"2013","unstructured":"Pitoia FBueno FUrciuoli CAbelleira ECross G & Tuttle RM. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American Thyroid Association and Latin American Thyroid Society risk of recurrence classification systems. Thyroid2013231401\u20131407. (https:\/\/doi.org\/10.1089\/thy.2013.0011)"}],"container-title":["European Thyroid Journal"],"original-title":[],"link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/12\/5\/ETJ-23-0110.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/12\/5\/ETJ-23-0110.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/12\/5\/ETJ-23-0110.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:51:49Z","timestamp":1784555509000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/etj\/article\/2897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":24,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/etj-23-0110","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}